Andrew J Wiemer Selected Research

Andrew J Wiemer Research Topics

Disease

15	Neoplasms (Cancer) 11/2023 - 06/2006
10	Leukemia 11/2023 - 11/2004
5	Osteoporosis 01/2010 - 06/2006
3	Multiple Myeloma 01/2019 - 06/2006
3	Bone Resorption 01/2008 - 06/2006
2	Hypercholesterolemia 01/2010 - 03/2008
2	Neoplasm Metastasis (Metastasis) 06/2009 - 03/2008
2	Bone Diseases (Bone Disease) 04/2008 - 01/2008
1	COVID-19 08/2020
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2019
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2019
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2019
1	Carcinogenesis 01/2019
1	Bacterial Infections (Bacterial Infection) 10/2018
1	Lymphoid Leukemia 01/2017
1	Rheumatoid Arthritis 01/2010
1	Inflammation (Inflammations) 01/2010
1	Bone Fractures (Bone Fracture) 06/2006

Drug/Important Bio-Agent (IBA)

7	ProdrugsIBA 01/2022 - 08/2014
5	Diphosphonates (Bisphosphonates)IBA 12/2018 - 06/2006
4	Farnesyltranstransferase (Farnesyltransferase)IBA 01/2019 - 03/2008
4	Terpenes (Terpenoids)IBA 10/2018 - 03/2008
3	InterferonsIBA 11/2023 - 12/2018
3	ButyrophilinsIBA 11/2023 - 12/2019
3	AntigensIBA 02/2023 - 01/2022
3	LigandsIBA 10/2020 - 10/2018
3	Diphosphates (Pyrophosphates)IBA 12/2018 - 11/2004
2	Immunoconjugates (Immunoconjugate)IBA 01/2022 - 01/2022
2	CytokinesIBA 01/2022 - 01/2010
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 06/2009
2	CaspasesIBA 01/2019 - 11/2016
2	TropoloneIBA 01/2019 - 11/2016
2	GeranyltranstransferaseIBA 01/2017 - 01/2008
2	EnzymesIBA 01/2010 - 06/2009
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2023
1	Surface Antigens (Surface Antigen)IBA 01/2022
1	Phosphates (Orthophosphate)IBA 08/2020
1	Antiviral Agents (Antivirals)IBA 08/2020
1	remdesivirIBA 08/2020
1	Acetates (Acetic Acid Esters)FDA Link 12/2019
1	LuciferasesIBA 12/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	Histones (Histone)IBA 01/2019
1	IronIBA 01/2019
1	hydroxide ionIBA 01/2019
1	Notch ReceptorsIBA 01/2019
1	Histone Deacetylases (Histone Deacetylase)IBA 09/2017
1	Histone Deacetylase InhibitorsIBA 09/2017
1	digeranyl bisphosphonateIBA 01/2017
1	Zoledronic Acid (Zometa)FDA Link 01/2017
1	benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketoneIBA 11/2016
1	Propidium (Propidium Iodide)IBA 11/2016
1	Annexin A5IBA 11/2016
1	Caspase 3 (Caspase-3)IBA 11/2016
1	N- methyl- N- (3- ((2- (2- oxo- 2,3- dihydro- 1H- indol- 5- ylamino)- 5- trifluoromethyl- pyrimidin- 4- ylamino)- methyl)- pyridin- 2- yl)- methanesulfonamideIBA 09/2013
1	Focal Adhesion Protein-Tyrosine KinasesIBA 09/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2010
1	ras ProteinsIBA 06/2009
1	mevalonate kinaseIBA 06/2009
1	isopreneIBA 03/2008
1	Mevalonic Acid (Mevalonate)IBA 06/2006
1	Monomeric GTP-Binding ProteinsIBA 06/2006
1	AlcoholsIBA 11/2004

Therapy/Procedure

2	Therapeutics 09/2017 - 06/2009
1	Intravenous Administration 01/2022
1	Aftercare (After-Treatment) 12/2019
1	Immunotherapy 08/2014